POLITICS

NEWS FLASH: Pfizer Is Working On Twice-Daily Pills That You’ll Take With Your Vaccines!

Do you think compulsory vaccinations were a terrible idea?

Do you consider never-ending booster shots to be a bad thing?

Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender

It’s about to get a whole lot worse.

It gets a lot worse.

Prepare to take a new “twice-a-day” medication in addition to the vaccine and the never-ending boosters!

Pfizer’s friendly “scientists” developed it, of course.

What could possibly go wrong?

With the exception of everything.

If you think I’m getting the flu shot, you’re wrong…but if you think I’m taking a Pfizer twice-daily pill, you’ve gone insane!

But it’s true, just look at this…

Pfizer’s Chairman and CEO is Albert Bourla….a nice guy, I’m sure!

And here’s the Press Release that went along with his Tweet, detailing how Pfizer wants you to take their medicines twice a day….(for the rest of your life?) :

First Participant Dosed in Phase 2/3 Study of Oral Antiviral Candidate in Non-Hospitalized Adults with COVID-19 Who Are at Low Risk of Severe Illness

New York, N.Y., September 1, 2021 – Pfizer Inc. (NYSE:PFE) today shared that the first participant has been dosed in a pivotal Phase 2/3 clinical trial to evaluate the safety and efficacy of PF-07321332 – an investigational orally administered protease inhibitor antiviral therapy designed specifically to combat COVID-19 – in non-hospitalized, symptomatic adult participants who have a confirmed diagnosis of SARS- CoV-2 infection and are not at increased risk of progressing to severe illness, which may lead to hospitalization or death.

The randomized, double-blind trial will enroll approximately 1,140 participants, who will receive PF- 07321332/ritonavir or placebo orally every 12 hours for five days.

Protease inhibitors, like PF-07321332, are designed to block the activity of the main protease enzyme that the coronavirus needs to replicate. Co-administration with a low dose of ritonavir is expected to help slow the metabolism, or breakdown, of PF-07321332 in order for it to remain in the body for longer periods of time at higher concentrations, thereby working continuously to help combat the virus. Ritonavir has previously been used in combination with other antivirals to similarly inhibit metabolism.

This study is part of a global clinical development program, consisting of multiple ongoing and planned clinical trials to evaluate this early-intervention, outpatient therapeutic candidate for potential use in a broad population of patients. The first registrational trial in this program, a pivotal Phase 2/3 study of PF- 07321332/ritonavir in non-hospitalized, symptomatic adult participants who have been diagnosed with SARS-CoV-2 infection and are at increased risk of progressing to severe illness, began enrollment in July 2021.

If successful, PF-07321332/ritonavir has the potential to address a significant unmet medical need, providing patients with a novel oral therapy that could be prescribed at the first sign of infection, without requiring hospitalization.

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.


This item sells for $39.95 on Amazon. Today's special promotion is offering a massive discount on this item. President Trump 2020 Coin (Gold & Silver Plated) - Claim 1 Free OR Claim a Discount + Free Shipping This coin is a symbol of President Trump's victory and success. Get Coin HERE Or Click on the image below.

Pharmaceutical megacorporation pfizer is now developing a COVID pill that is meant to be taken alongside the COVID vaccines that have already made the company a staggering amount of money. The new pill is expected to be released by the end of the year and will be required to be taken twice per day.

“Success against #COVID19 will likely require both vaccines & treatments,” Pfizer CEO Albert Bourla said on Wednesday. “We’re pleased to share we’ve started a Phase 2/3 study of our oral antiviral candidate-specifically designed to combat SARS-CoV-2-in non-hospitalized, low-risk adults.”

Pfizer also put out a press release the same week that proclaimed, “If successful, [the drug] has the potential to address a significant unmet medical need, providing patients with a novel oral therapy that could be prescribed at the first sign of infection, without requiring hospitalization.” The company described the drug as an “investigational orally administered protease inhibitor antiviral therapy designed specifically to combat COVID–19 – in non–hospitalized, symptomatic adult participants who have a confirmed diagnosis of SARS–CoV–2 infection and are not at increased risk of progressing to severe illness, which may lead to hospitalization or death.”

Media corporations have already expressed excitement about the new pill, and Pfizer is so confident that the pill will be swiftly approved and mandated by governments that it has already started a production line before the end of clinical trials.

Other companies are also hard at work on COVID pills to be taken indefinitely while governments and media corporations focus on COVID.

In Singapore, a 16-year-old boy was ruled to be eligible for a $225,000 settlement this week after suffering a myocarditis cardiac arrest event that doctors ruled was likely in response to receiving his first dose of the Pfizer BionTech vaccine, with the Ministry of Health stating, “The myocarditis was likely a serious adverse event arising from the COVID-19 vaccine he received, which might have been aggravated by his strenuous lifting of weights and his high consumption of caffeine through energy drinks and supplements.”

In response tweets like this, I was overjoyed to see people waking up:

Yes, it is exactly right!

Do you want to know what I’m taking instead?

I’m going to start by giving you a hefty disclaimer…..

DISCLAIMER: I am not a medical professional and do not practice medicine.

Clif High isn’t either!

Neither of us is providing medical advice to you.

Ok?

Ok.

However, I am adhering to Clif High’s advice (and others).

Why?

Because they are logical!

And because, no matter what, I don’t think I can go wrong with some additional vitamins right now, right?

And, let’s face it, I think I can do better than “doctors” like Dr. Fraudci and Dr. Birxx, who deceive you and dish you a heaping pile of propaganda!

You’ll probably be able to do everything they say.

But what I can say is that it appears that some pretty basic things can help you recover and safeguard your body in the future!

Vitamin C, Vitamin D, Chaga Mushroom Tea, C60, and, of course, hydroxychloroquine and ivermectin, could all be very helpful!

I have some links for you if you scroll down.

And, in the worst-case situation, taking additional vitamins is nearly always a good thing, right?

Regardless of which virus is circulating, your body requires them.

It’s nearly never a bad thing to give your body more vitamins as long as you don’t take too many fat-soluble vitamins.

Let me fill you in on Clif’s background and why he’s making these recommendations.

 

Source
www.bbc.com www.washingtonpost.com www.welovetrump.com

Margaret Taylor

Experienced communications professional with 10 years of experience in international journalism.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Adblock Detected

For continue reading on the site please disable the Ad-block